Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders??? Equity

v3.22.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Retained Deficit
Accumulated Deficit Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2019   8,304,030      
Beginning balance at Dec. 31, 2019 $ 50,193 $ 0 $ 77,431 $ (31,933) $ 4,695
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (25,895)     (25,895)  
Stock issuance (in shares)   2,574,374      
Stock issuance 18,087   18,087    
Share-based compensation expense 1,652   1,652    
Shares repurchase (in shares)   (233,788)      
Share repurchase $ (6,250)   (6,250)    
Stock option exercise (in shares) 88,706 88,707      
Stock option exercise $ 20   20    
Issuance of common shares upon vesting of RSUs (in shares)   2,989      
Share exchange, net (in shares)   717,085      
Conversion of Convertible Debentures (in shares)   984,567      
Conversion of Convertible Debentures 9,850   9,850    
Common shares issued for exercise of warrants (in shares)   300,000      
Common shares issued for exercise of warrants 3   3    
Conversion of the redeemable non-controlling interest (in shares)   1,562,339      
Conversion of the redeemable non-controlling interest 0   4,695   (4,695)
Business combination and PIPE financing (in shares)   10,582,721      
Business combination and PIPE financing 47,794   47,794    
Accretion of Class D preferred shares to liquidation preference on automatic conversion 0   10,219 (10,219)  
Reclassification and other (204)   763 (967)  
Ending balance (in shares) at Dec. 31, 2020   24,883,024      
Ending balance at Dec. 31, 2020 95,250 $ 0 164,264 (69,014) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (45,726)     (45,726)  
Share-based compensation expense $ 11,451   11,451    
Founders earnout shares vested (in shares)   570,212      
Stock option exercise (in shares) 40,942 40,942      
Stock option exercise $ 10   10    
Issuance of common shares upon vesting of RSUs (in shares)   268,895      
Exercise of warrants (in shares)   122,639      
Exercise of warrants 1,410   1,410    
Beneficial conversion feature of Convertible Note 4,748   4,748    
Conversions of Convertible Note to common shares (in shares)   720,085      
Conversions of Convertible Note to common shares 6,047   6,047    
Reclassification and other (420)   (420)    
Ending balance (in shares) at Dec. 31, 2021   26,605,797      
Ending balance at Dec. 31, 2021 $ 72,770 $ 0 $ 187,510 $ (114,740) $ 0